Index by author

March 01, 2010; Volume 77,Issue 3

A

  1. Aneiros-Fernández, José

    1. Palpable purpura
      Salvador Arias-Santiago, MD, José Aneiros-Fernández, MD, María Sierra Girón-Prieto, MD, María Antonia Fernández-Pugnaire, PhD and Ramón Naranjo-Sintes, PhD
      Cleveland Clinic Journal of Medicine March 2010, 77 (3) 205-206; DOI: https://doi.org/10.3949/ccjm.77a.09065

      A healthy 47-year-old woman presents with a 3-day history of widespread asymptomatic lesions in the extremities, fever, arthralgias, and mild abdominal pain. What is the diagnosis?

  2. Aragon, George

    1. When and how to evaluate mildly elevated liver enzymes in apparently healthy patients
      George Aragon, MD and Zobair M. Younossi, MD, MPH
      Cleveland Clinic Journal of Medicine March 2010, 77 (3) 195-204; DOI: https://doi.org/10.3949/ccjm.77a.09064

      Not all asymptomatic people with a mildly elevated liver enzyme value need an extensive evaluation, which can be costly, anxiety-provoking, and risky.

  3. Arias-Santiago, Salvador

    1. Palpable purpura
      Salvador Arias-Santiago, MD, José Aneiros-Fernández, MD, María Sierra Girón-Prieto, MD, María Antonia Fernández-Pugnaire, PhD and Ramón Naranjo-Sintes, PhD
      Cleveland Clinic Journal of Medicine March 2010, 77 (3) 205-206; DOI: https://doi.org/10.3949/ccjm.77a.09065

      A healthy 47-year-old woman presents with a 3-day history of widespread asymptomatic lesions in the extremities, fever, arthralgias, and mild abdominal pain. What is the diagnosis?

B

  1. Bartholomew, John R.

    1. Interpreting the Jupiter trial: Statins can prevent VTE, but more study is needed
      Alejandro Perez, MD and John R. Bartholomew, MD
      Cleveland Clinic Journal of Medicine March 2010, 77 (3) 191-194; DOI: https://doi.org/10.3949/ccjm.77a.09077

      The incidence of venous thromboembolism in people taking rosuvastatin (Crestor) 20 mg/day was about half that in people taking placebo. This was a relatively healthy population, and the incidence in both groups was low.

F

  1. Fernández-Pugnaire, María Antonia

    1. Palpable purpura
      Salvador Arias-Santiago, MD, José Aneiros-Fernández, MD, María Sierra Girón-Prieto, MD, María Antonia Fernández-Pugnaire, PhD and Ramón Naranjo-Sintes, PhD
      Cleveland Clinic Journal of Medicine March 2010, 77 (3) 205-206; DOI: https://doi.org/10.3949/ccjm.77a.09065

      A healthy 47-year-old woman presents with a 3-day history of widespread asymptomatic lesions in the extremities, fever, arthralgias, and mild abdominal pain. What is the diagnosis?

G

  1. Girón-Prieto, María Sierra

    1. Palpable purpura
      Salvador Arias-Santiago, MD, José Aneiros-Fernández, MD, María Sierra Girón-Prieto, MD, María Antonia Fernández-Pugnaire, PhD and Ramón Naranjo-Sintes, PhD
      Cleveland Clinic Journal of Medicine March 2010, 77 (3) 205-206; DOI: https://doi.org/10.3949/ccjm.77a.09065

      A healthy 47-year-old woman presents with a 3-day history of widespread asymptomatic lesions in the extremities, fever, arthralgias, and mild abdominal pain. What is the diagnosis?

M

  1. Mandell, Brian F.

    1. Vaccination: An option not to be ignored
      Brian F. Mandell, MD, PhD
      Cleveland Clinic Journal of Medicine March 2010, 77 (3) 151; DOI: https://doi.org/10.3949/ccjm/77a/03001

      Outbreaks of measles are seemingly on the rise, mainly because of lower vaccination rates, which are in part due to the unfounded fear that the vaccine causes autism.

  2. Mastronarde, John G.

    1. Treating silent reflux disease does not improve poorly controlled asthma
      Brent P. Riscili, MD, Jonathan P. Parsons, MD, MSc and John G. Mastronarde, MD, MSc
      Cleveland Clinic Journal of Medicine March 2010, 77 (3) 155-160; DOI: https://doi.org/10.3949/ccjm.77a.09111

      A recent multicenter trial indicated that empirically prescribing a proton pump inhibitor does not help control asthma symptoms and that current guidelines need to be reevaluated.

N

  1. Naranjo-Sintes, Ramón

    1. Palpable purpura
      Salvador Arias-Santiago, MD, José Aneiros-Fernández, MD, María Sierra Girón-Prieto, MD, María Antonia Fernández-Pugnaire, PhD and Ramón Naranjo-Sintes, PhD
      Cleveland Clinic Journal of Medicine March 2010, 77 (3) 205-206; DOI: https://doi.org/10.3949/ccjm.77a.09065

      A healthy 47-year-old woman presents with a 3-day history of widespread asymptomatic lesions in the extremities, fever, arthralgias, and mild abdominal pain. What is the diagnosis?

O

  1. Olin, Jeffrey W.

    1. Stenting for atherosclerotic renal artery stenosis: One poorly designed trial after another
      Mitchell D. Weinberg, MD and Jeffrey W. Olin, DO
      Cleveland Clinic Journal of Medicine March 2010, 77 (3) 164-171; DOI: https://doi.org/10.3949/ccjm.77a.10001

      The three randomized trials of stenting vs medical therapy published so far are so seriously flawed that it is impossible to make treatment decisions based on their results.

P

  1. Parsons, Jonathan P.

    1. Treating silent reflux disease does not improve poorly controlled asthma
      Brent P. Riscili, MD, Jonathan P. Parsons, MD, MSc and John G. Mastronarde, MD, MSc
      Cleveland Clinic Journal of Medicine March 2010, 77 (3) 155-160; DOI: https://doi.org/10.3949/ccjm.77a.09111

      A recent multicenter trial indicated that empirically prescribing a proton pump inhibitor does not help control asthma symptoms and that current guidelines need to be reevaluated.

  2. Perez, Alejandro

    1. Interpreting the Jupiter trial: Statins can prevent VTE, but more study is needed
      Alejandro Perez, MD and John R. Bartholomew, MD
      Cleveland Clinic Journal of Medicine March 2010, 77 (3) 191-194; DOI: https://doi.org/10.3949/ccjm.77a.09077

      The incidence of venous thromboembolism in people taking rosuvastatin (Crestor) 20 mg/day was about half that in people taking placebo. This was a relatively healthy population, and the incidence in both groups was low.

R

  1. Riscili, Brent P.

    1. Treating silent reflux disease does not improve poorly controlled asthma
      Brent P. Riscili, MD, Jonathan P. Parsons, MD, MSc and John G. Mastronarde, MD, MSc
      Cleveland Clinic Journal of Medicine March 2010, 77 (3) 155-160; DOI: https://doi.org/10.3949/ccjm.77a.09111

      A recent multicenter trial indicated that empirically prescribing a proton pump inhibitor does not help control asthma symptoms and that current guidelines need to be reevaluated.

S

  1. Sabella, Camille

    1. Measles: Not just a childhood rash
      Camille Sabella, MD
      Cleveland Clinic Journal of Medicine March 2010, 77 (3) 207-213; DOI: https://doi.org/10.3949/ccjm.77a.09123

      Outbreaks continue to be reported in communities with a high number of unvaccinated people. Most cases are linked to international travel.

  2. Simon, James F.

    1. Stenting atherosclerotic renal arteries: Time to be less aggressive
      Stenting atherosclerotic renal arteries: Time to be less aggressive
      James F. Simon, MD
      Cleveland Clinic Journal of Medicine March 2010, 77 (3) 178-189; DOI: https://doi.org/10.3949/ccjm.77a.09098

      It is time to strongly reconsider the current aggressive approach to revascularization of stenotic renal arteries and to take a more coordinated, critical approach.

W

  1. Weinberg, Mitchell D.

    1. Stenting for atherosclerotic renal artery stenosis: One poorly designed trial after another
      Mitchell D. Weinberg, MD and Jeffrey W. Olin, DO
      Cleveland Clinic Journal of Medicine March 2010, 77 (3) 164-171; DOI: https://doi.org/10.3949/ccjm.77a.10001

      The three randomized trials of stenting vs medical therapy published so far are so seriously flawed that it is impossible to make treatment decisions based on their results.

Y

  1. Younossi, Zobair M.

    1. When and how to evaluate mildly elevated liver enzymes in apparently healthy patients
      George Aragon, MD and Zobair M. Younossi, MD, MPH
      Cleveland Clinic Journal of Medicine March 2010, 77 (3) 195-204; DOI: https://doi.org/10.3949/ccjm.77a.09064

      Not all asymptomatic people with a mildly elevated liver enzyme value need an extensive evaluation, which can be costly, anxiety-provoking, and risky.

Back to top

In this issue